Anti-JC virus antibodies: implications for PML risk stratification.
Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M.
Gorelik L, et al.
Ann Neurol. 2010 Sep;68(3):295-303. doi: 10.1002/ana.22128.
Ann Neurol. 2010.
PMID: 20737510